| Terminated | IMPACT of AspireSR® for VNS Therapy on Healthcare Resource Utilisation and Clinical Outcomes. Epilepsy | — | 2022-01-20 |
| Active Not Recruiting | Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation Obstructive Sleep Apnea, OSA, Apnea | N/A | 2021-07-27 |
| Terminated | Non-interventional Study Describing Healthcare Resource Utilisation and Clinical Outcomes Associated With VNS Epilepsy | — | 2021-05-11 |
| Terminated | The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Asse Treatment Resistant Depression | — | 2021-03-23 |
| Withdrawn | XLTCS - Accelerometer Data Collection in an Epilepsy Monitoring Unit (EMU) Epilepsy, Tonic-Clonic | — | 2020-03-16 |
| Recruiting | A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of Treatment Resistant Depression | N/A | 2019-09-26 |
| Terminated | ANTHEM-HFrEF Pivotal Study Heart Failure, Heart Failure, Congestive, Heart Failure, Systolic | N/A | 2018-05-01 |
| Completed | Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study Epilepsies, Partial, Epilepsy, Tonic-Clonic | N/A | 2018-02-27 |
| Completed | Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System. Epilepsy, Seizures, Drug Resistant Epilepsy | — | 2018-02-05 |
| Recruiting | A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Treat Depression. Treatment Resistant Depression | — | 2017-12-14 |
| Completed | Clinical Evaluation of LEft VEntricular Auto Threshold Algorithm (LEVEA) Heart Failure | N/A | 2017-02-16 |
| Completed | PErsonalized and Adaptive Kinesthetic stImulation Therapy, Based on Cardio-respiratory Holter moNitoring, for Obstructive Sleep Apnea Syndrome | N/A | 2016-06-01 |
| Terminated | The remedē® System for the Treatment of Central Sleep Apnea in Daily Practice Sleep Apnea, Central Sleep Disordered Breathing | — | 2016-02-01 |
| Terminated | Mitroflow DL Post Approval Study- North America Aortic Stenosis, Aortic Regurgitation, Aortic Valve Insufficiency | N/A | 2015-03-01 |
| Completed | VAgal Nerve Stimulation: safeGUARDing Heart Failure Patients Heart Failure With Reduced Ejection Fraction | Phase 2 | 2014-10-07 |
| Completed | HYpopnea and Apnea Detection and Treatment Performance of a New cardiOreSpiratory Holter Monitor Sleep Apnea, Obstructive | — | 2014-09-01 |
| Completed | Left Ventricular Pacing Vectors Effectiveness to Narrow Phrenic Nerve Stimulation Heart Failure | N/A | 2012-11-01 |
| Terminated | Clinical Evaluation Of The Nano Lv Lead System In Chronic Situation (LENEA) LV Lead, LV Therapy, LV Treatment | Phase 2 / Phase 3 | 2012-10-31 |
| Completed | Optimization With SonR Method in the ClinicAl pRactice CRT Patients | — | 2012-07-01 |
| Completed | Evolution of the PR Interval in Patients Implanted With a Pacemaker Using the SafeR Mode Sinus Node Dysfunction, Atrioventricular Block | — | 2012-04-01 |
| Completed | Evaluation of the Performances of the Sleep Disordered Breathing Monitoring Function in Pacemaker Bradycardia | Phase 3 | 2012-03-01 |
| Withdrawn | Clinical Evaluation of the Sorin Group's REPLY MR-conditional Pacing System Dual-chamber Pacemaker Placement | Phase 3 | 2012-01-01 |
| Completed | Clinical Evaluation Of The PARADYM RF Device Heart Failure | Phase 3 | 2010-10-01 |
| Completed | Clinical Evaluation Of The SonR Atrial Lead In Paradym RF Device Heart Failure | Phase 3 | 2010-10-01 |
| Completed | Monitoring of Syncopes and/or Sustained Palpitations of Suspected Arrhythmic Origin With External Loop-Recorde Syncope, Palpitations | — | 2010-08-01 |
| Completed | Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device Heart Failure | Phase 3 | 2009-09-01 |
| Terminated | Clinical Status Monitoring in Implantable Cardiac Defibrillator (ICD) Patients by Physiological Diagnosis (PhD Heart Failure | Phase 4 | 2009-09-01 |
| Completed | An Observational Study on the Sorin Group New Brady Leads XFine and Beflex Pacing Leads Implantation | — | 2008-07-01 |
| Completed | Predictive Risk Stratification Through T Variability in ICD Patients Without Pacing Indications Sudden Cardiac Death | Phase 4 | 2007-12-01 |
| Completed | Evaluation of the SafeR Mode in Patients With a Dual Chamber Pacemaker Indication Assess the Benefits From the AAISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients. | Phase 4 | 2007-12-01 |
| Completed | Impact of Ventricular Pacing in Unselected ICD/CRT-D Patients Ventricular Tachycardia, Ventricular Fibrillation | — | 2007-11-01 |
| Completed | Echocardiography and Peak Endocardial Acceleration (PEA) Measurements in Cardiac Resynchronization Therapy (CR Congestive Heart Failure | — | 2007-10-01 |
| Completed | Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers Patients Implanted With a Pacemaker | — | 2007-06-01 |
| Completed | Optimal Anti-tachycardia Therapy in Implantable Cardioverter-defibrillator (ICD) Patients Without Pacing Indic Tachycardia | Phase 4 | 2006-06-01 |
| Completed | Biventricular Tachycardias Outcome Trial Biventricular Tachycardias | Phase 4 | 2006-05-01 |
| Completed | Clinical Evaluation on Advanced Resynchronization Heart Failure, Cardiomyopathy | Phase 4 | 2005-11-01 |
| Completed | Prevention of Atrial Arrhythmia in Patients Without Atrioventricular (AV) Conduction Disease Sinus Node Dysfunction, Brady Tachy Syndrome | Phase 4 | 2004-07-01 |
| Completed | Ventricular Arrhythmias Incidence According to Sleep Apnea Syndrome in Implantable Cardioverter-Defibrillator Sleep Apnoea | Phase 4 | 2004-04-01 |
| Completed | Spontaneous Atrio Ventricular Conduction Preservation Sinus Node Dysfunction, Bradycardia-Tachycardia Syndrome, Paroxysmal Atrioventricular Block | Phase 4 | 2003-11-01 |
| Withdrawn | Sleep Apnea, Arrhythmias and Cardiac Reverse Remodeling in Heart Failure Patients Sleep Breathing Disorders in the Responders to Cardiac Resynchronisation Therapy (CRT) | Phase 4 | — |